Pluri Prices $1.25M Chairman-Led Placement at $1.50, a Premium to Market
PLUR is trading near its 52-week low of $0.85 (6.5% above the low).
Summary
Pluri finalized terms of its chairman's $1.25M June advance: 833,334 shares at $1.50 plus 833,334 warrants at $1.65, a price well above today's $0.905. No new cash comes in, but the dilution lands on a company already flagged with going-concern doubt and thin runway.
Key Events · Financing and Capital Events · PLUR
-
Chairman's Advance Converted to Priced Shares
Chutzpah Holdings LP, beneficially owned by chairman and largest shareholder Alexandre Weinstein, receives 833,334 common shares at $1.50 per share plus a warrant for 833,334 shares at a $1.65 strike, against the $1.25M advance paid June 16, 2026.
-
No New Cash at Closing
The $1.25M already paid is applied in full to the purchase price; no additional subscription payment is due at closing, so the transaction adds no fresh liquidity.
-
Dilution From Shares and Warrant
833,334 shares are issued now, with up to 833,334 more issuable on warrant exercise — roughly 1.67M potential shares against a company with an $11.4M market cap.
-
Warrant Terms and Ownership Cap
The warrant becomes exercisable six months after its October 23, 2026 issue date and expires five years after that; a 35% beneficial ownership blocker caps how much the holder can accumulate, and transfers require company consent.
Analysis · PLUR · Life Sciences
Pluri's chairman and largest shareholder, Alexandre Weinstein, is converting a $1.25M advance he paid in June into 833,334 shares at $1.50 plus an equal number of warrants struck at $1.65. That $1.50 share price is well above today's $0.905 quote, so the deal brings in no new cash now but does price insider capital at a premium to the current market. The real weight of the news is the backdrop: the 10-K disclosed going-concern doubt and less than three months of cash runway, and the company has been cutting its ATM and leaning on a $200M shelf. This placement adds roughly 833,334 shares plus up to 833,334 more on warrant exercise — meaningful dilution for a company this size — and the warrants cannot be exercised until six months after the October 23, 2026 issue date, so they are not an immediate cash source. The 35% ownership blocker limits how much Weinstein can accumulate through the warrant.
How filings like this one have moved
In the 30 days to Oct 20, 2026, 29.2% of the 1466 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PLUR was trading at $0.91 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $11.4M. The 52-week trading range was $0.85 to $4.87. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.